Background:
The focus of this study was to prepare and characterize the single-chain variable fragment
antibody (scFv)-coupled immunoaffinity column for purification of subtilisin BRC.
Methods:
The scFv against subtilisin BRC was immobilized onto CNBr-activated Sepharose 4B. Adsorption isotherm for
subtilisin BRC on scFv-BRC-coupled Sepharose 4B was obtained and calculated the maximum binding capacity. The
extraction conditions including eluting solution, the concentration of eluting solution and flow rate were optimized. Under
the optimized eluting conditions, the dynamic binding capacity of the immunoaffinity column was determined.
Results:
The scFv-BRC-coupled Sepharose 4B for immunoaffinity purification of subtilisin BRC was prepared. The
coupling efficiency was about 78.4%, e.g. about 8 mg of scFv-BRC was covalently coupled to 1 g CNBr-activated
Sepharose 4B. The maximum equilibrium binding capacity (qm) and dissociation constant (Kd) of the immunoaffinity
column for subtilisin BRC were 3.01 mg/mL and 0.465 mg/mL, respectively. The immunoaffinity chromatography
conditions were optimized and the subtilisin BRC was purified 3.29-fold with 55.6%.
Conclusion:
The subtilisin BRC was effectively purified with high purity using scFv-BRC-coupled Sepharose 4B and the
dynamic binding capacity of the column was determined. These results suggested that scFv-BRC can be used as a ligand
for affinity purification of subtilisin BRC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.